Omnicell Net Profit Margin 2010-2025 | OMCL

Omnicell net profit margin from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue.
Omnicell Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2025-03-31 $1.14B $0.02B 1.94%
2024-12-31 $1.11B $0.01B 1.17%
2024-09-30 $1.06B $-0.02B -1.60%
2024-06-30 $1.08B $-0.02B -1.85%
2024-03-31 $1.10B $-0.02B -1.90%
2023-12-31 $1.15B $-0.02B -1.74%
2023-09-30 $1.19B $-0.03B -2.86%
2023-06-30 $1.24B $-0.02B -1.86%
2023-03-31 $1.27B $-0.02B -1.34%
2022-12-31 $1.30B $0.01B 0.46%
2022-09-30 $1.31B $0.05B 3.67%
2022-06-30 $1.26B $0.06B 4.77%
2022-03-31 $1.20B $0.07B 5.92%
2021-12-31 $1.13B $0.08B 6.80%
2021-09-30 $1.07B $0.08B 7.38%
2021-06-30 $0.99B $0.06B 5.97%
2021-03-31 $0.92B $0.04B 3.83%
2020-12-31 $0.89B $0.03B 3.58%
2020-09-30 $0.89B $0.04B 4.26%
2020-06-30 $0.91B $0.05B 5.40%
2020-03-31 $0.92B $0.07B 7.47%
2019-12-31 $0.90B $0.06B 6.80%
2019-09-30 $0.86B $0.05B 6.27%
2019-06-30 $0.84B $0.05B 5.74%
2019-03-31 $0.81B $0.04B 4.83%
2018-12-31 $0.79B $0.04B 4.95%
2018-09-30 $0.77B $0.06B 7.12%
2018-06-30 $0.76B $0.05B 6.49%
2018-03-31 $0.75B $0.04B 5.89%
2017-12-31 $0.71B $0.03B 4.35%
2017-09-30 $0.69B $0.01B 1.30%
2017-06-30 $0.68B $0.00B 0.44%
2017-03-31 $0.67B $0.00B 0.00%
2016-12-31 $0.70B $0.01B 1.44%
2016-09-30 $0.65B $0.01B 1.38%
2016-06-30 $0.60B $0.02B 2.50%
2016-03-31 $0.54B $0.03B 4.64%
2015-12-31 $0.48B $0.03B 6.40%
2015-09-30 $0.48B $0.03B 6.72%
2015-06-30 $0.46B $0.03B 6.68%
2015-03-31 $0.46B $0.03B 6.58%
2014-12-31 $0.44B $0.03B 6.79%
2014-09-30 $0.43B $0.03B 6.57%
2014-06-30 $0.41B $0.03B 7.13%
2014-03-31 $0.40B $0.03B 6.82%
2013-12-31 $0.38B $0.02B 6.30%
2013-09-30 $0.37B $0.02B 6.30%
2013-06-30 $0.36B $0.02B 6.20%
2013-03-31 $0.34B $0.02B 5.06%
2012-12-31 $0.31B $0.02B 5.11%
2012-09-30 $0.29B $0.01B 4.90%
2012-06-30 $0.27B $0.01B 3.76%
2012-03-31 $0.25B $0.01B 4.76%
2011-12-31 $0.25B $0.01B 4.49%
2011-09-30 $0.24B $0.01B 3.35%
2011-06-30 $0.23B $0.01B 2.60%
2011-03-31 $0.23B $0.01B 2.22%
2010-12-31 $0.22B $0.01B 2.25%
2010-09-30 $0.22B $0.01B 2.27%
2010-06-30 $0.22B $0.01B 2.29%
2010-03-31 $0.22B $0.00B 1.85%
2009-12-31 $0.21B $0.00B 0.47%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.346B $1.112B
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.674B 58.11
Tempus AI (TEM) United States $11.334B 0.00
Doximity (DOCS) United States $11.302B 52.32
Hims & Hers Health (HIMS) United States $9.269B 96.30
IRhythm Technologies (IRTC) United States $4.836B 0.00
Inspire Medical Systems (INSP) United States $3.893B 60.83
Hinge Health (HNGE) United States $3.474B 0.00
Privia Health (PRVA) United States $2.652B 181.25
Enovis (ENOV) United States $1.835B 10.23
Phreesia (PHR) United States $1.643B 0.00
Schrodinger (SDGR) United States $1.509B 0.00
10x Genomics (TXG) United States $1.436B 0.00
Azenta (AZTA) United States $1.397B 64.92
Clover Health Investments (CLOV) United States $1.394B 0.00
Evolent Health (EVH) United States $1.257B 107.10
Claritev (CTEV) United States $0.687B 0.00
Fulgent Genetics (FLGT) United States $0.596B 0.00
Veradigm (MDRX) United States $0.487B 0.00
Butterfly Network (BFLY) United States $0.487B 0.00
Standard BioTools (LAB) United States $0.475B 0.00
Talkspace (TALK) United States $0.452B 135.00
Outset Medical (OM) United States $0.347B 0.00
TruBridge (TBRG) United States $0.343B 762.00
Nyxoah SA (NYXH) Belgium $0.265B 0.00
Health Catalyst (HCAT) United States $0.262B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.211B 0.00
KORU Medical Systems (KRMD) United States $0.157B 0.00
EUDA Health Holdings (EUDA) Singapore $0.136B 0.00
American Well (AMWL) United States $0.116B 0.00
CareCloud (CCLD) United States $0.107B 4.06
Pulmonx (LUNG) United States $0.106B 0.00
MDxHealth SA (MDXH) Belgium $0.105B 0.00
111 (YI) China $0.067B 0.00
HeartBeam (BEAT) United States $0.048B 0.00
P3 Health Partners (PIII) United States $0.044B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.043B 0.00
Zepp Health (ZEPP) Netherlands $0.037B 0.00
Zhongchao (ZCMD) China $0.031B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.017B 0.00
Bullfrog AI Holdings (BFRG) United States $0.015B 0.00
Healthcare Triangle (HCTI) United States $0.013B 0.00
MSP Recovery (MSPR) United States $0.011B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00